"Lacinov\u00E1, Zde\u0148ka" . "RIV/00216208:11110/14:10272439" . "Mr\u00E1z, Milo\u0161" . "17" . "Diabetologie, metabolismus, endokrinologie, vyziva." . "How does adipose tissue contribute to the development of metabolic complications of obesity?"@en . . "I" . . . . "CZ - \u010Cesk\u00E1 republika" . . . "RIV/00216208:11110/14:10272439!RIV15-MSM-11110___" . . . "[F69B1F56E11F]" . "http://www.tigis.cz/images/stories/DMEV/2014/02/04_haluzik_dmev_2-14.pdf" . . . "Zvy\u0161uj\u00EDc\u00ED se v\u00FDskyt obezity p\u0159edstavuje jeden z nejz\u00E1sadn\u011Bj\u0161\u00EDch probl\u00E9m\u016F sou\u010Dasn\u00E9 medic\u00EDny. \u00DAzk\u00E9 propojen\u00ED obezity s inzul\u00EDnovou rezistenc\u00ED, diabetem 2. typu, arteri\u00E1ln\u00ED hypertenz\u00ED, dyslipid\u00E9mii a \u0159adou dal\u0161\u00EDch onemocn\u011Bn\u00ED ozna\u010Dovan\u00E9 jako metabolick\u00FD syndrom v\u00FDznamn\u011B zvy\u0161uje kardiovaskul\u00E1rn\u00ED riziko ob\u00E9zn\u00EDch pacient\u016F a jejich morbiditu i mortalitu z kardiovaskul\u00E1rn\u00EDch p\u0159\u00ED\u010Din. V posledn\u00EDch dvaceti letech byla odhalena a podrobn\u011B studov\u00E1na v\u00FDznamn\u00E1 aktivn\u00ED \u00FAloha tukov\u00E9 tk\u00E1n\u011B v metabolick\u00FDch regulac\u00EDch a jej\u00ED pod\u00EDl na etiopatogeneze prakticky v\u0161ech metabolick\u00FDch komplikac\u00ED obezity. V tomto \u010Dl\u00E1nku p\u0159in\u00E1\u0161\u00EDme p\u0159ehled t\u011Bchto mechanism\u016F a diskutujeme mo\u017En\u00E9 perspektivy vyu\u017Eit\u00ED jejich ovlivn\u011Bn\u00ED v prevenci a l\u00E9\u010Db\u011B obezity a p\u0159idru\u017Een\u00FDch metabolick\u00FDch onemocn\u011Bn\u00ED." . . "3"^^ . "2" . "Increasing prevalence obesity represents one of the most significant problems of current medicine. Tight interconnestion of obesity with insulin resistance, type 2 diabetes, arterial hypertension, dyslipidemia and many other pathologies commonly referred to as metabolic syndrome markedly increases cardiovascular risk of obese patients and their cardiovascular risk of obese patients and their cardiovascular morbidity and mortality. During the last twenty years, important active involvement of adipose tissue in metabolic regulations and its role in the etiopathogenesis of almost all metabolic complications of obesity has been discovered and intensively studied. In this paper we provide an overview of these mechanisms and discuss possible perspectives of their utilization in the prevention and treatment of obesity and its related metabolic diseases."@en . . . "Haluz\u00EDk, Martin" . "Jak tukov\u00E1 tk\u00E1\u0148 p\u0159isp\u00EDv\u00E1 ke vzniku metabolick\u00FDch komplikac\u00ED obezity?" . "1211-9326" . . "3"^^ . "11110" . . "Jak tukov\u00E1 tk\u00E1\u0148 p\u0159isp\u00EDv\u00E1 ke vzniku metabolick\u00FDch komplikac\u00ED obezity?"@cs . "6"^^ . "Zvy\u0161uj\u00EDc\u00ED se v\u00FDskyt obezity p\u0159edstavuje jeden z nejz\u00E1sadn\u011Bj\u0161\u00EDch probl\u00E9m\u016F sou\u010Dasn\u00E9 medic\u00EDny. \u00DAzk\u00E9 propojen\u00ED obezity s inzul\u00EDnovou rezistenc\u00ED, diabetem 2. typu, arteri\u00E1ln\u00ED hypertenz\u00ED, dyslipid\u00E9mii a \u0159adou dal\u0161\u00EDch onemocn\u011Bn\u00ED ozna\u010Dovan\u00E9 jako metabolick\u00FD syndrom v\u00FDznamn\u011B zvy\u0161uje kardiovaskul\u00E1rn\u00ED riziko ob\u00E9zn\u00EDch pacient\u016F a jejich morbiditu i mortalitu z kardiovaskul\u00E1rn\u00EDch p\u0159\u00ED\u010Din. V posledn\u00EDch dvaceti letech byla odhalena a podrobn\u011B studov\u00E1na v\u00FDznamn\u00E1 aktivn\u00ED \u00FAloha tukov\u00E9 tk\u00E1n\u011B v metabolick\u00FDch regulac\u00EDch a jej\u00ED pod\u00EDl na etiopatogeneze prakticky v\u0161ech metabolick\u00FDch komplikac\u00ED obezity. V tomto \u010Dl\u00E1nku p\u0159in\u00E1\u0161\u00EDme p\u0159ehled t\u011Bchto mechanism\u016F a diskutujeme mo\u017En\u00E9 perspektivy vyu\u017Eit\u00ED jejich ovlivn\u011Bn\u00ED v prevenci a l\u00E9\u010Db\u011B obezity a p\u0159idru\u017Een\u00FDch metabolick\u00FDch onemocn\u011Bn\u00ED."@cs . "Jak tukov\u00E1 tk\u00E1\u0148 p\u0159isp\u00EDv\u00E1 ke vzniku metabolick\u00FDch komplikac\u00ED obezity?"@cs . "Jak tukov\u00E1 tk\u00E1\u0148 p\u0159isp\u00EDv\u00E1 ke vzniku metabolick\u00FDch komplikac\u00ED obezity?" . . . "cardiovascular complications; adipokines; adipose tissue; Obesity"@en . "23172" . "How does adipose tissue contribute to the development of metabolic complications of obesity?"@en .